News

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...
Despite mixed results, analysts maintained faith in ivonescimab’s ability to cross over between Eastern and Western patient ...
The consortium's goal is to build the largest enterprise AI supercomputer in Sweden, once it becomes operational.
The deal with Evopoint boosts Astellas' claudin pipeline as other CLDN18.2 candidates come through the industry pipeline from ...
The winners of the RIBA East Awards 2025 were unveiled at a ceremony on 15 May, at which Young’s Court Development at ...
chief medical officer and Oncology chief development officer at AstraZeneca. "Building on the Niagara data, this outcome demonstrates our strategy of bringing novel therapies to patients with ...
Ericsson said that the new AI infra will support compute-intensive AI tasks, including the training of specialized AI models.
THIS BUILDING AND THESE LABS ARE SCHEDULED TO ... one of the largest facilities dedicated exclusively to cell therapy at AstraZeneca's Rockville facility."It gives us hope. I mean, it really ...
AstraZeneca completes acquisition of biotech company, EsoBiotec: Cambridge, UK Wednesday, May 21, 2025, 09:00 Hrs [IST] AstraZeneca announced the successful completion of the acqu ...
Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has ...
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announces a ...